Summary
The effects of centrally administered NPY on the brain monoamine systems were investigated in the rat. Neuropeptide Y (0.2–5.0 nmol), its C-terminal 13–36 amino acid (a.a.) fragment, NPY13–36 (0.4–10.0 nmol), or saline were injected into the right lateral cerebral ventricle of unrestrained rats. After l h the animals were decapitated, and the brains were taken out. Two cortical regions (‘frontal’ and ‘parietal’), the striatum, the hypothalamus, and the brain stem were dissected out. The tissue contents of noradrenaline (NA), dopamine (DA) and serotonin (5-HT), as well as of their major metabolites, 3-methoxy-4-hydroxy-phenylethylené glycol (MHPG), 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxy-indole acetic acid (5-HIAA) were measured. The most consistent finding was a dose-related increase of both DA and DOPAC levels after treatment with NPY. This effect was reproduced by NPY13–36 in cortical tissue, whereas, in the sub-cortical regions, NPY13–36 only reproduced the effects of NPY on the DOPAC levels. Less consistent effects were found on the NA systems, in which NA levels showed a tendency to increase following low, and decrease after high doses of NPY. These effects were largely reproduced by NPY13–36. In addition, NPY increased tissue levels of MHPG in frontal cortical tissue in a dose-related manner. The brain 5-HT systems were not affected.
Similar content being viewed by others
References
Agnati LF, Fuxe K, Benfenati F, Battistini N, Härfstrand A, Tatemoto K, Hökfelt T, Mutt V (1983) Neuropeptide Y in vitro selectivity increases the number of alpha-2-adrenergic binding sites in membranes of the medulla oblongata of the rat. Acta Physiol Scand 118: 293–295
Albers HE, Ferris CF, Leeman SE, Goldman BD (1984) Avian pancreatic polypeptide phase shifts hamster circadian rhythms when microinjected into the suprachiasmatic region. Science 223: 833–835
Beal MF, Frank RC, Ellison DW, Martin JB (1986) The effect of neuropeptide Y on striatal catecholamines. Neurosci Lett 71: 118–123
Carlsson A (1978) Mechanism of action of neuroleptic drugs. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 1057–1070
Chronwall BM, Chase TN, O'Donohue TL (1984) Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neurons. Neurosci Lett 52: 213–217
Chronwall BM, DiMaggio DA, Massari VJ, Pickel VM, Ruggiero DA, O'Donohue TL (1985) The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 15: 1159–1181
Colmers WF, Lukowiak K, Pittman QJ (1985) Neuropeptide Y reduces orthodromically evoked population spike in rat hippocampal CA 1 by a possibly presynaptic mechanism. Brain Res 346: 404–408
Eriksson BM, Persson BA (1982) Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection. J Chromatogr 228: 143–154
Everitt BJ, Hökfelt T, Terenius L, Tatemoto K, Mutt V, Goldstein M (1984) Differential co-existence of neuropeptide Y (NPY)-like immunoreactiviy with catecholamines in the central nervous system of the rat. Neuroscience 11: 443–462
Fuxe K, Agnati LF, Härfstrand A, Zini I, Tatemoto K, Pich EM, Hökfelt T, Mutt V, Terenius L (1983) Central administration of neuropeptide Y induces hypotension, bradypnea and EEG synchronization in the rat. Acta Physiol Scand 118: 189–192
Haas HL, Hermann A, Greene RW, Chan-Palay V (1987) Action and location of neuropeptide tyrosine (Y) on hippocampal neurons of the rat in slice preparations. J Comp Neurol 257: 208–215
Heilig M, Murison R (1987) Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat. Regul Pept 19: 221–231
Heilig M, Murison R (1987) Intracerebroventricular neuropeptide Y protects against stressinduced gastric erosion in the rat. Eur J Pharmacol 137: 127–129
Heilig M, Wahlestedt C, Ekman R, Widerlöv E (1988) Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. Eur J Pharmacol 147: 465–467
Heilig M, Wahlestedt C, Widerlöv E (1988) Neuropeptide Y (NPY) induced activity suppression in the rat: evidence for NPY receptor heterogeneity and for interaction with alpha-adrenergic receptors. Eur J Pharmacol 157: 205–213
Heilig M, Söderpalm B, Engel JA, Widerlöv E (1989) Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology (in press)
Hendry SH, Jones EG, DeFelipe J, Schmechel D, Brandon C, Emson PC (1984) Neuropeptide-containing neurons of the cerebral cortex are also GABAergic. Proc Natl Acad Sci U.S.A. 81: 6526–6530
Härfstrand A, Eneroth P, Agnati L, Fuxe K (1987) Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to hypothalamic catecholamines. Regul Pept 17: 167–179
Iversen SD (1977) Brain dopamine systems and behaviour. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of Psychopharmacology, vol 8. Plenum Press, New York, pp 333–384
Kalra SP, Crowley WR (1984) Norepinephrine-like effects of neuropeptide Y on LH release in the rat. Life Sci 35: 1173–1176
Kerkerian L, Bosler O, Pelletier G, Nieoullon A (1986) Striatal neuropeptide Y neurones are under the influence of the nigrostriatal dopaminergic pathway: immunohistochemical evidence. Neurosci Lett 66: 106–122
Levine AS, Morley JE (1984) Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides 5: 1025–1029
Lundberg JM, Terenius L, Hökfelt T, Martling CR, Tatemoto K, Mutt V, Polak J, Bloom S, Goldstein M (1982) Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 116: 477–480
Modigh K (1987) Antidepressant drugs in anxiety disorders. Acta Psychiatr Scand 76 [Suppl 335]: 51–57
Monti JM (1982) Catecholamines and the sleep-wake cycle. I. EEG and behavioural arousal. Life Sci 30: 1145–1157
Redmond DE, Huang YH (1979) New evidence for a locus coeruleus-norepinephrine connection with anxiety. Life Sci 25: 2149–2162
Siever LJ, Davies KL (1985) Overview: towards a dysregulation hypothesis of depression. Am J Psychiatry 142: 1017–1031
Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296: 659–666
Undén A, Tatemoto K, Mutt V, Bartfai T (1984) Neuropeptide Y receptor in the rat brain. Eur J Biochem 145: 525–530
Vallejo M, Carter DA, Biswas S, Lightman SL (1987) Neuropeptide Y alters monoamine turnover in the rat brain. Neurosci Lett 73: 155–160
Wahlestedt C, Yanaihara N, Håkanson R (1986) Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept 13: 307–318
Wahlestedt C, Skagerberg G, Ekman R, Heilig M, Sundler F, Håkanson R (1987) Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res 417: 33–38
Wahlestedt C, Edvinson L, Ekblad E, Håkanson R (1988) Effects of neuropeptide Y at sympathetic neuroeffector junctions: existence of Y1 and Y2 receptors. In: Nobin A, Owman C (eds) Neuronal Messengers in Vascular Function. Elsevier, Amsterdam
Wahlestedt C, Ekman R, Widerlöv E (1989) Neuropeptide Y (NPY) and the central nervous system: distribution, effects and possible relationship to neurological and psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 13: 31–54
Westlind-Danielsson A, Undén A, Abens J, Andell S, Bartfai T (1987) Neuropeptide Y receptors and the inhibition of adenylate cyclase in the human frontal and temporal cortex. Neurosci Lett 74: 237–242
Widerlöv E, Lewander T (1978) Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after alpha-Methyl-p-Tyrosine; time- and dose-response relationships. Naunyn-Schmiedebergs Arch Pharmacol 304: 111–123
Widerlöv E, Lindström LH, Wahlestedt C, Ekman R (1988) Neuropeptide Y and peptide YY as possible cerebrospinal markers for major depression and schizophrenia, respectively. J Psychiatr Res 22 (1): 69–79
Widerlöv E, Heilig M, Ekman R, Wahlestedt C (1989) Neuropeptide Y—possible involvement in depression and anxiety. In: Mutt V, Fuxe K, Hökfelt T (eds) Nobel Conference on NPY. Raven Press, New York
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heilig, M., Vècséi, L., Wahlestedt, C. et al. Effects of centrally administered neuropeptide Y (NPY) and NPY13–36 on the brain monoaminergic systems of the rat. J. Neural Transmission 79, 193–208 (1990). https://doi.org/10.1007/BF01245130
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01245130